Advances in medical imaging for the diagnosis and management of common genitourinary cancers.

Abstract

Medical imaging of the 3 most common genitourinary (GU) cancers-prostate adenocarcinoma, renal cell carcinoma, and urothelial carcinoma of the bladder-has evolved significantly during the last decades. The most commonly used imaging modalities for the diagnosis, staging, and follow-up of GU cancers are computed tomography, magnetic resonance imaging (MRI), and positron emission tomography (PET). Multiplanar multidetector computed tomography and multiparametric MRI with diffusion-weighted imaging are the main imaging modalities for renal cell carcinoma and urothelial carcinoma, and although multiparametric MRI is rapidly becoming the main imaging tool in the evaluation of prostate adenocarcinoma, biopsy is still required for diagnosis. Functional and molecular imaging using 18-fluorodeoxyglucose-PET and sodium fluoride-PET are essential for the diagnosis, and especially follow-up, of metastatic GU tumors. This review provides an overview of the latest advances in the imaging of these 3 major GU cancers.

• Authors: Mohammad H Bagheri, Mark A Ahlman, Liza Lindenberg, Baris Turkbey, Jeffrey Lin, Ali Cahid Civelek, Ashkan A Malayeri, Piyush K Agarwal, Peter L Choyke, Les R Folio, Andrea B Apolo
• Journal: Urologic oncology (Urol Oncol) Vol. 35 Issue 7 Pg. 473-491 (07 2017) ISSN: 1873-2496 [Electronic] United States
• PMID: 28506596 (Publication Type: Journal Article, Review, Research Support, N.I.H., Extramural)
• Copyright: Published by Elsevier Inc.

Topics

• Female
• Humans
• Magnetic Resonance Imaging (methods)
• Male
• Positron-Emission Tomography (methods)
• Urogenital Neoplasms (diagnosis, diagnostic imaging, therapy)